{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:25:04Z","timestamp":1783013104002,"version":"3.54.6"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"1002-A The Scientific Technological Research Council of Turkey","award":["Project number: 124S439."],"award-info":[{"award-number":["Project number: 124S439."]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s10096-026-05445-0","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:18:17Z","timestamp":1773832697000},"page":"1917-1927","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["`Successful treatment of VRE-infected mice with vancomycin through restoration of susceptibility using vanA antisense RNA"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6336-4018","authenticated-orcid":false,"given":"Melis","family":"Yalcin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asude G\u00fclce","family":"Oryasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulkerim","family":"Karaynir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marc","family":"Rolain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00fclent","family":"Bozdogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"issue":"1","key":"5445_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/595011","volume":"48","author":"HW Boucher","year":"2009","unstructured":"Boucher HW, Talbot GH, Bradley JS, Edwards JE, Gilbert D, Rice LB, Boucher H, Talbot G, Bradley J, Edwards J, Rice L, Scheld M, Spellberg B, Bartlett J (2009) Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48(1):1\u201312. https:\/\/doi.org\/10.1086\/595011","journal-title":"Clin Infect Dis"},{"key":"5445_CR2","unstructured":"Centers for Disease Control and Prevention (CDC) (2019) Antibiotic resistance threats in the United States, 2019. https:\/\/www.cdc.gov\/drugresistance\/pdf\/threats-report\/2019-ar-threats-report-508.pdf. Accessed 3 Jun 2025"},{"issue":"1","key":"5445_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51065-4","volume":"9","author":"H Elsana","year":"2019","unstructured":"Elsana H, Olusanya TOB, Carr-Wilkinson J, Darby S, Faheem A, Elkordy AA (2019) Evaluation of novel cationic gene-based liposomes with cyclodextrin prepared by thin film hydration and microfluidic systems. Sci Rep 9(1):15120. https:\/\/doi.org\/10.1038\/s41598-019-51065-4","journal-title":"Sci Rep"},{"key":"5445_CR4","unstructured":"Food and Drug Administration (FDA) (2023) Zyvox (linezolid) prescribing information. https:\/\/www.accessdata.fda.gov.\u00a0Accessed 5 Jun 2025"},{"key":"5445_CR5","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/biomedicines9040416","volume":"9","author":"S Jani","year":"2021","unstructured":"Jani S, Ramirez MS, Tolmasky ME (2021) Silencing antibiotic resistance with antisense oligonucleotides. Biomedicines 9:416. https:\/\/doi.org\/10.3390\/biomedicines9040416","journal-title":"Biomedicines"},{"issue":"3","key":"5445_CR6","first-page":"1236","volume":"53","author":"J Meng","year":"2009","unstructured":"Meng J, Kang J, Liu S, Chen H (2009) Antisense inhibition of mecA in MRSA restores \u03b2-lactam susceptibility. Antimicrob Agents Chemother 53(3):1236\u20131241","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"5445_CR7","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1128\/AAC.01542-08","volume":"53","author":"J Meng","year":"2009","unstructured":"Meng J, Wang H, Hou Z, Chen T, Fu J, Ma X, He G, Xue X, Jia M, Luo X (2009) Novel anion liposome-encapsulated antisense oligonucleotide restores susceptibility of methicillin-resistant Staphylococcus aureus and rescues mice from lethal sepsis by targeting mecA. Antimicrob Agents Chemother 53(7):2871\u20132878. https:\/\/doi.org\/10.1128\/AAC.01542-08","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"5445_CR8","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.3390\/ijms15022773","volume":"15","author":"N Nakashima","year":"2014","unstructured":"Nakashima N, Miyazaki K (2014) Bacterial cellular engineering by genome editing and gene silencing. Int J Mol Sci 15(2):2773\u20132793. https:\/\/doi.org\/10.3390\/ijms15022773","journal-title":"Int J Mol Sci"},{"key":"5445_CR9","doi-asserted-by":"publisher","first-page":"217","DOI":"10.2147\/IDR.S54125","volume":"8","author":"T O\u2019Driscoll","year":"2015","unstructured":"O\u2019Driscoll T, Crank CW (2015) Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist 8:217\u2013230. https:\/\/doi.org\/10.2147\/IDR.S54125","journal-title":"Infect Drug Resist"},{"issue":"1","key":"5445_CR10","first-page":"7063","volume":"21","author":"A Patel","year":"2021","unstructured":"Patel A, Vaghasiya H (2021) Vancomycin-resistant enterococci (VRE): a challenge to researchers and clinicians. J Cell Tissue Res 21(1):7063\u20137067","journal-title":"J Cell Tissue Res"},{"issue":"3","key":"5445_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1586\/eri.13.12","volume":"11","author":"JN Pendleton","year":"2013","unstructured":"Pendleton JN, Gorman SP, Gilmore BF (2013) Clinical relevance of the ESKAPE pathogens. Expert Rev Anti-Infect Ther 11(3):297\u2013308. https:\/\/doi.org\/10.1586\/eri.13.12","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"1","key":"5445_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.21608\/jbaar.2025.419043","volume":"11","author":"T Qader","year":"2025","unstructured":"Qader T, Ali M, Alsakini A (2025) Genotyping and siRNA-mediated quorum sensing inhibition in Staphylococcus aureus: exploring new approaches for treating persistent infections. J Biosci Appl Res 11(1):196\u2013213. https:\/\/doi.org\/10.21608\/jbaar.2025.419043","journal-title":"J Biosci Appl Res"},{"issue":"4","key":"5445_CR13","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.jgar.2014.04.002","volume":"2","author":"S Ranotkar","year":"2014","unstructured":"Ranotkar S, Kumar P, Zutshi S, Prashanth KS, Bezbaruah B, Anand J, Lahkar M (2014) Vancomycin-resistant enterococci: troublemaker of the 21st century. J Glob Antimicrob Resist 2(4):205\u2013212. https:\/\/doi.org\/10.1016\/j.jgar.2014.04.002","journal-title":"J Glob Antimicrob Resist"},{"key":"5445_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-016-0007-z","volume":"21","author":"F Saberi","year":"2016","unstructured":"Saberi F, Kamali M, Najafi A et al (2016) Natural antisense RNAs as mRNA regulatory elements in bacteria: a review on function and applications. Cell Mol Biol Lett 21:6. https:\/\/doi.org\/10.1186\/s11658-016-0007-z","journal-title":"Cell Mol Biol Lett"},{"key":"5445_CR15","unstructured":"Said MS, Tirthani E, Lesho E (2022) Enterococcus infections. StatPearls. StatPearls Publishing"},{"key":"5445_CR16","doi-asserted-by":"publisher","unstructured":"Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: a laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press. https:\/\/doi.org\/10.1002\/jobm.3620300824","DOI":"10.1002\/jobm.3620300824"},{"key":"5445_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-7-233","volume":"7","author":"B Shrum","year":"2014","unstructured":"Shrum B, Anantha RV, Xu SX et al (2014) A robust scoring system to evaluate sepsis severity in an animal model. BMC Res Notes 7:233. https:\/\/doi.org\/10.1186\/1756-0500-7-233","journal-title":"BMC Res Notes"},{"issue":"2","key":"5445_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/IPC.0000000000000469","volume":"25","author":"S Si","year":"2017","unstructured":"Si S, Durkin MJ, Mercier MM, Yarbrough ML, Liang SY (2017) Successful treatment of prosthetic joint infection due to vancomycin-resistant enterococci with tedizolid. Infect Dis Clin Pract 25(2):105\u2013107. https:\/\/doi.org\/10.1097\/IPC.0000000000000469","journal-title":"Infect Dis Clin Pract"},{"issue":"2","key":"5445_CR19","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/jac\/dkad123","volume":"79","author":"PC Silva","year":"2024","unstructured":"Silva PC, Souza AL, Costa MC (2024) Emergence of VanN\u2010type glycopeptide resistance in Enterococcus faecalis clinical isolates. J Antimicrob Chemother 79(2):345\u2013352. https:\/\/doi.org\/10.1093\/jac\/dkad123","journal-title":"J Antimicrob Chemother"},{"issue":"19","key":"5445_CR20","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare11101946","volume":"11","author":"RF Silva","year":"2023","unstructured":"Silva RF, Ramos GR, Carmo AM (2023) Multidrug-resistant bacteria and the global challenge of antimicrobial resistance. Healthcare 11(19):1946. https:\/\/doi.org\/10.3390\/healthcare11101946","journal-title":"Healthcare"},{"issue":"3","key":"5445_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1093\/jac\/dkw476","volume":"72","author":"EK Sully","year":"2017","unstructured":"Sully EK, Geller BL, Li L et al (2017) Peptide-conjugated phosphorodiamidate morpholino oligomer (PPMO) restores carbapenem susceptibility to NDM-1-positive pathogens in vitro and in vivo. J Antimicrob Chemother 72(3):782\u2013790. https:\/\/doi.org\/10.1093\/jac\/dkw476","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"5445_CR22","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1124\/molpharm.124.000895","volume":"106","author":"GM Traber","year":"2024","unstructured":"Traber GM, Yu AM (2024) The growing class of novel RNAi therapeutics. Mol Pharmacol 106(1):13\u201320. https:\/\/doi.org\/10.1124\/molpharm.124.000895","journal-title":"Mol Pharmacol"},{"key":"5445_CR23","doi-asserted-by":"publisher","first-page":"126963","DOI":"10.1016\/j.micres.2021.126963","volume":"257","author":"P Vyas","year":"2022","unstructured":"Vyas P, Harish (2022) Anti-CRISPR proteins as a therapeutic agent against drug- resistant bacteria. Microbiol Res 257:126963. https:\/\/doi.org\/10.1016\/j.micres.2021.126963","journal-title":"Microbiol Res"},{"issue":"3","key":"5445_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2025.101997","volume":"6","author":"C Wang","year":"2025","unstructured":"Wang C, Sheng W, Zhou Y, Hang X, Zhao J, Gu Y, Meng X, Bai Y, Li W, Zhang Y, Zhang L, Yu J, Zhou Z, Li X, Sun H, Xue Y, Xu T, Zen K, Ling H, Zhang CY, Bi H, Wang H (2025) SiRNA-AGO2 complex inhibits bacterial gene translation: a promising therapeutic strategy for superbug infection. Cell Rep Med 6(3):101997. https:\/\/doi.org\/10.1016\/j.xcrm.2025.101997","journal-title":"Cell Rep Med"},{"key":"5445_CR25","unstructured":"World Health Organization (WHO) (2017) The selection and use of essential medicines: report of the WHO expert committee, 2017 (including the 20th WHO Model List of Essential Medicines and the 6th WHO Model List of Essential Medicines for Children). WHO technical report series, no. 1006. https:\/\/apps.who.int\/iris\/handle\/10665\/273826.\u00a0Accessed 3 Jun 2025"},{"key":"5445_CR26","unstructured":"World Health Organization (WHO) (2017) WHO publishes list of bacteria for which new antibiotics are urgently needed.\u00a0https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed.\u00a0Accessed 3 Jun 2025"},{"issue":"2","key":"5445_CR27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.5578\/mb.202498191","volume":"58","author":"M Yal\u00e7in","year":"2024","unstructured":"Yal\u00e7in M, Kurtulu\u015f M, Bozdo\u011fan B (2024) Silencing of resistance mechanism in vancomycin-resistance enterococci using antisense RNA of vanA gene. Mikrobiyol Bul 58(2):125\u2013134. https:\/\/doi.org\/10.5578\/mb.202498191","journal-title":"Mikrobiyol Bul"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05445-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05445-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T17:03:51Z","timestamp":1783011831000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05445-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["5445"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05445-0","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]},"assertion":[{"value":"8 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Animal Experiments Local Ethics Committee of Ayd\u0131n Adnan Menderes University (ADU-HADYEK), Turkey (Approval No: 64583101\/2023\/04; 19 January 2023). All procedures were carried out in accordance with relevant institutional and national guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}